MedTrace Logo

Efficacy and Safety With Ziprasidone in First-episode Psychosis

NCT01157559 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2010-07-07

No results posted yet for this study

Summary

The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.

Conditions

  • First Episode Psychosis

Interventions

DRUG

Ziprasidone

8 week prospective study

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2008-06-30
Completion
2010-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01157559 on ClinicalTrials.gov